This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Université Pierre Et Marie Curie (Paris 6), Institut Curie, Institute Curie. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 158 
3 out of 162 
2 out of 11 Years Active: 2016-2019
Title: **Innovative Contributions of Fariba Nemati in Cancer Research**
Introduction
Fariba Nemati, an accomplished inventor based in Paris, France, has made significant strides in the field of cancer research through her patented innovations. With a total of five patents to her name, her work focuses on developing methods and tools that enhance the efficacy of cancer treatments.
Latest Patents
Among her most recent contributions is a pioneering method for predicting a patient's response to anti-tumor treatments. This invention provides an in vitro approach for assessing the likelihood that a patient with a tumor will respond to treatment using a pro-apoptotic peptide. The method involves evaluating the expression levels of essential genes, including VIM, MK167, TCF7L2, NEK2, BIRC5, MCL1, and PLK1 within the patient's biological samples.
Another significant patent pertains to peptide inhibitors that target the interaction between the TEAD and YAP or TAZ proteins. These isolated peptide inhibitors, which also include a derived chimeric peptide linked to a cell-penetrating peptide, exhibit cytotoxic activity and are particularly beneficial in treating hyperproliferative disorders such as cancer.
Career Highlights
Fariba Nemati has cultivated her expertise while working at prestigious institutions, including the Université Pierre et Marie Curie (Paris 6) and the Institut Curie. These environments have provided her with access to cutting-edge research and collaboration opportunities, enabling her to develop her innovative patented technologies.
Collaborations
Throughout her career, Fariba has collaborated with notable colleagues such as Angelita Rebollo Garcia and Didier Decaudin. These partnerships have fostered a dynamic exchange of ideas and facilitated advancements in cancer treatment methodologies.
Conclusion
Fariba Nemati's work exemplifies the critical role that inventors play in advancing scientific research and technology. Her innovative patents not only enhance the understanding of cancer treatment responses but also offer promising avenues for the development of effective treatments. As she continues to push the boundaries of research, her contributions will undoubtedly have lasting impacts on the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile